(Q28201984)

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-kappaB as a primary regulator of the stress response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Activators and target genes of Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Is NF-kappaB the sensor of oxidative stress?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Staphylococcus aureus and derived exotoxins induce nuclear factor kappa B-like activity in murine bone marrow macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Activation of nuclear factor-kappaB in the rat brain after transient focal ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Insulin Activates Nuclear Factor κB in Mammalian Cells through a Raf-1-mediated Pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Activation of NF-kappa B and immunoglobulin expression in response to platelet-activating factor in a human B cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Platelet-activating factor (PAF) positively auto-regulates the expression of human PAF receptor transcript 1 (leukocyte-type) through NF-kappa B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

IkappaBalpha degradation is not a requirement for the X-ray-induced activation of nuclear factor kappaB in normal rat astrocytes and human brain tumour cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Site-specific tyrosine phosphorylation of IkappaBalpha negatively regulates its inducible phosphorylation and degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Severe liver degeneration in mice lacking the IkappaB kinase 2 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Limb and skin abnormalities in mice lacking IKKalpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NEMO/IKK gamma-deficient mice model incontinentia pigmenti.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

A cytokine-responsive IκB kinase that activates the transcription factor NF-κB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Direct Phosphorylation of IB by IKK and IKK: Discrimination Between Free and NF-B-Bound Substrate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U2OS cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Immunodeficiency in protein kinase cbeta-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-kappa B activation in tumor necrosis factor alpha-stimulated neutrophils is mediated by protein kinase Cdelta. Correlation to nuclear Ikappa Balpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Up-regulation of protein kinase C-epsilon promotes the expression of cytokine-inducible nitric oxide synthase in RAW 264.7 cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The essential role of MEKK3 in TNF-induced NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NAK is an IkappaB kinase-activating kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Hematopoietic progenitor kinase-1 (HPK1) stress response signaling pathway activates IkappaB kinases (IKK-alpha/beta) and IKK-beta is a developmentally regulated protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Activation of the Hematopoietic Progenitor Kinase-1 (HPK1)-dependent, Stress-activated c-Jun N-terminal Kinase (JNK) Pathway by Transforming Growth Factor β (TGF-β)-activated Kinase (TAK1), a Kinase Mediator of TGF β Signal Transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Activation of NF-kappa B by oncogenic Raf in HEK 293 cells occurs through autocrine recruitment of the stress kinase cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Transactivation by the p65 subunit of NF-kappaB in response to interleukin-1 (IL-1) involves MyD88, IL-1 receptor-associated kinase 1, TRAF-6, and Rac1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Protein tyrosine kinase p56lck is required for ceramide-induced but not tumor necrosis factor-induced activation of NF-kappa B, AP-1, JNK, and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Vanadate induction of NF-kB involves IkB kinase B and SAPK/ERK kinasa 1 in macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Innovative treatment programs against cancer: II. Nuclear factor-kappaB (NF-kappaB) as a molecular target

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Discovery and design of selective cyclooxygenase-2 inhibitors as non-ulcerogenic, anti-inflammatory drugs with potential utility as anti-cancer agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The possible role of TNF-alpha and IL-2 in inducing tumor-associated metabolic alterations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Significant correlation between expression of interleukin-1alpha and liver metastasis in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Prognostic significance of the combined expression of matrix metalloproteinase-9, urokinase type plasminogen activator and its receptor in breast cancer as measured by Northern blot analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Chemokines: not just leukocyte chemoattractants in the promotion of cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Effects of roxithromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Genomic organization of human and mouse genes for vascular endothelial growth factor C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Efficient adenoviral transfer of NF-kappaB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IkappaBalpha overexpression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Survival-independent function of NF-κB⧹Rel during late stages of thymocyte differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-κB Activation Is a Critical Regulator of Human Granulocyte Apoptosisin Vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-kappaB is activated and promotes cell death in focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Nitric oxide inhibits stress-induced endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Cytokine induced expression of porcine inhibitor of apoptosis protein (iap) family member is regulated by NF-kappa B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

c-Rel Arrests the Proliferation of HeLa Cells and Affects Critical Regulators of the G1/S-Phase Transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Cellular proliferation and activation of NF kappa B are induced by autocrine production of tumor necrosis factor alpha in the human T lymphoma line HuT 78.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NFkappaB prevents apoptosis and liver dysfunction during liver regeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Down-regulation of NF-kappaB activity and NF-kappaB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Enhanced radiosensitivity by inhibition of nuclear factor kappaB activation in human malignant glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-κB-mediated Induction ofmdr1bExpression by Insulin in Rat Hepatoma Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Aberrant rel/nfkb genes and activity in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

PRAD1/lCyclin D1 proto‐oncogene: Genomic organization, 5′ dna sequence, and sequence of a tumor‐specific rearrangement breakpoint

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Identification of a tumor-associated mutant form of the NF-kappaB RelA gene with reduced DNA-binding and transactivating activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Physical interaction of the bHLH LYL1 protein and NF-kappaB1 p105

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The guanylate cyclase-coupled natriuretic peptide receptor: a new target for prevention of cold ischemia-reperfusion damage of the rat liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-kappaB, AP-1, and c-Jun N-terminal kinase. Comparison with interleukin-13.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Inhibition of NF-κB Binding to DNA by Chromium, Cadmium, Mercury, Zinc, and Arsenitein Vitro:Evidence of a Thiol Mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein/c-Jun

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Lactacystin, proteasome function, and cell fate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The effect of sodium salicylate and aspirin on NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Inhibition of NF-kappaB DNA binding by nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Assessing induction of I kappa B by nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Sanguinarine (Pseudochelerythrine) Is a Potent Inhibitor of NF-κB Activation, IκBα Phosphorylation, and Degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

IL-10 down-regulates human microglial IL-8 by inhibition of NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Structure, regulation and function of NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Glutathione downregulates the phosphorylation of I kappa B: autoloop regulation of the NF-kappa B-mediated expression of NF-kappa B subunits by TNF-alpha in mouse vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Antioxidants inhibit stimulation of HIV transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Activation of Nuclear Factor-κB in Cultured Endothelial Cells by Increased Glucose Concentration: Prevention by Calphostin C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

An allosteric drug, o,o'-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

TAT fusion proteins containing tyrosine 42-deleted IkappaBalpha arrest osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Duration of nuclear NF-kappaB action regulated by reversible acetylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-alpha-induced NF-kappa B1 transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Transcriptional cross talk between NF-kappaB and p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

p300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Requirement of NF-κB Activation to Suppress p53-Independent Apoptosis Induced by Oncogenic Ras

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Association of Cdk2/cyclin E and NF-kappa B complexes at G1/S phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Role of NF-κB in p53-mediated programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

TRAF6 is a signal transducer for interleukin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Human 4-1BB (CD137) Signals Are Mediated by TRAF2 and Activate Nuclear Factor-κB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Identification and characterization of an IkappaB kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021

Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402482

7 January 2021